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Abstract: The present investigation evaluates the capacity of Allium ursinum (Wild garlic) 20 
leaf lyophilisate (WGLL; alliin content: 0.261%) to mitigate cardiovascular damage in 21 
hypercholesterolemic rabbits. New Zealand rabbits were divided into three groups: (i) 22 
cholesterol-free rabbit chow (control); (ii) rabbit chow, containing 2% cholesterol (HC); 23 
(iii) rabbit chow containing 2% cholesterol + 2% WGLL (HCT); for 8 weeks. At the 0- and 24 
8-week timepoints, echocardiographic measurements were made, along with determination 25 
of basic serum parameters. Following the treatment period, after ischemia-reperfusion 26 
injury, hemodynamic parameters were measured using an isolated working heart model. 27 
Western blot analyses of heart tissue followed for evaluating protein expression and 28 
histochemical study for the atheroma status determination. WGLL treatment mediated 29 
increases in fractional shortening; right ventricular function; peak systolic velocity; 30 
tricuspidal annular systolic velocity in live animals; along with improved aortic and 31 
coronary flow. Western blot analysis revealed WGLL-associated increases in HO-1 protein 32 
and decreases in SOD-1 protein production. WGLL-associated decreases were observed in 33 
aortic atherosclerotic plaque coverage; plasma ApoB and activity of LDH and CK in 34 
plasma. Plasma LDL was also significantly reduced. The results clearly demonstrate that 35 
WGLL has complex cardioprotective effects, suggesting future strategies for its use in 36 
prevention and therapy for atherosclerotic disorders. 37 
Keywords: Allium species; atherosclerosis; lipoprotein; cardiovascular homeostasis; 38 
echocardiography. 39 
1. Introduction 40 
Wild garlic (Allium ursinum L.) is a wild plant belonging to the Amaryllidaceae family. 41 
It is distributed widely in Asia and Europe, and known variously as bear’s garlic, buckrams, 42 
bear’s leek, wood garlic, and ransoms [1]. The intense flavor of the plant makes it a popular 43 
flavoring and regular dietary component for people and animals living in regions where it 44 
grows [2]. The mild garlic-like scent of the plant is attributable to its content of 45 
sulfur-containing compounds. These include, prominently, sulfoxides and glutamyl peptides. 46 
The species also contains high levels of odorless, non-volatile metabolites: 47 
S-alk(en)yl-l-cysteine-sulfoxides, which hydrolyze under physiological conditions to 48 
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volatile (poly)sulfides and thiosulphinates, imparting the characteristic odor and flavor of the 49 
plant [3]. Wild garlic also contains high levels of polyphenolic compounds, particularly in 50 
leaves and bulbs – which accounts substantially for antioxidant and therapeutic properties of 51 
these sections of the plant [4-6]. It also combines two additional health-enhancing properties: 52 
the plant has approximately 20 times the level of adenosine as common garlic (Allium 53 
sativum), plus it has significantly higher levels of ajoene, both of which combine to stabilize 54 
blood pressure and cholesterol levels, reduce excessive thrombocyte aggregation, and 55 
improve physiological control of cholesterol metabolism [7]. Indeed, the cardiovascular 56 
benefits of using this plant were observed to be so substantial that the Association for the 57 
Protection and Research on European Medicinal Plants designated it “Plant of the Year” for 58 
1992 [7]. However, contrary to common garlic, wild garlic has not been studied in clinical 59 
trials, and although its cardiovascular effect may be hypothesized based on its chemical 60 
constituents, the preclinical confirmation is rather incomplete. A. ursinum was also selected 61 
as the subject of the present investigation based on outcomes of previous work by this 62 
laboratory demonstrating cardioprotective properties of other plant extracts derived from 63 
traditional medicines [8,9].  64 
Hypercholesterolemia, a syndrome characterized by abnormally elevated levels of blood 65 
cholesterol and lipoproteins[10,11], was chosen as a model disease for the present study due 66 
to its association with a wide range of pathologies, particularly atherosclerosis [12], with 67 
associated thrombosis, stroke, and heart failure [13]. Although A. ursinum is not typically 68 
used as a stand-alone medication, its anti-atherogenic properties are well known, to the extent 69 
it is used as a dietary treatment for these disorders at Bucharest University Hospital in 70 
Romania [14]. In vitro evaluation for effects of several A ursinum fresh leaf extract 71 
preparations on aggregation of human platelets, revealed that ADP-induced aggregation was 72 
significantly suppressed by ethanolic extracts. The observed data suggested similarity of 73 
pharmacological action to Clopidogrel a thienopyridine clot formation inhibitor that is a 74 
potent antiplatelet drug [15].  A likely explanation for this outcome is the known 75 
antiaggregatory properties of the β-sitosterol 3-O-β-D-glucopyranoside and 76 
1,2-di-O-α-linolenoyl-3-O-β-D-galactopyranosyl-sn-glycerol (DLGG) components of A 77 
ursinum [16].    It was further noted that 45-day administration of feed supplemented with 78 
1% w/w wild garlic Allium ursinum (wild garlic), or alternatively with 1% w/w Allium 79 
sativum (cultivated garlic) to spontaneously hypertensive rats (SHR), in groups of 10 animals 80 
per experiment mediated significant reduction in final mean systolic blood pressure (SBP) 81 
[17]. 82 
 The possible underlying mechanisms include the ability of Ramson to inhibit the activity of 83 
angiotensin-converting enzyme (ACE). In vitro tests on the water extract from the leaves (at 84 
the concentration of 0.300 mg/ml) showed significantly increased activity on enzyme 85 
inhibition when compared to leaves with extract of garlic (58 vs. 30%) [7]. Moreover, 86 
significantly lower levels of ACE activity were noted in blood of animals fed for 8 weeks 87 
with a standard rodent chow containing 2% pulverized  whole leaf A. ursinum, versus 88 
untreated control rats [18]. 89 
 90 
 91 
The physiologic significance of hypercholesterolemia induced by elevated cholesterol in 92 
feed administered to animals is particularly well illustrated by consideration of how such 93 
diets affect inflammatory processes, dysregulation of which, imposes increased oxidative 94 
stress on a wide range of tissues, and to which cells of the cardiovascular system are 95 
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particularly sensitive[19]. For example, pigs maintained on diets supplemented with 2% 96 
cholesterol, exhibited impairment of coronary endothelial function associated with decreased 97 
capacity to neutralize free radicals, decreased expression of nitric oxide synthetase and 98 
elevate activation of nuclear factor-kappa beta, a pro-inflammatory transcription factor[20]. 99 
Outcomes of these investigations underscore the particular significance of 100 
hypercholesterolemia for investigation of cardiac function – as was demonstrated in by gene 101 
transfer studies conducted [21,22]. 102 
Previous work by the authors shows that methods of extraction used to recover, purify, 103 
and concentrate plant products may cause some degradation in the bioactivity of component 104 
molecules [23]. For this reason, lyophilization was used to process the A. ursinum 105 
administered to animals in the present study. This method is easily accomplished, and 106 
optimally preserves the native properties of extracted biological molecules [24]. 107 
2. Results 108 
2.1. Bioanalytical Analysis of Wild Garlic Leaf Lyophilisate.  109 
Alliin (S-Allyl-L-cysteine sulfoxide) is a nonprotein amino acid abundant in most of the 110 
Allium species. It is the natural substrate of alliinase. Therefore, its content in the pure form is 111 
commonly analyzed by HPLC. The percentage of total alliin was analyzed by HPLC. 112 
Analysis of a representative lyophilized sample revealed the leaf to contain 0.261% alliin by 113 
weight (RSD% = 0.45%). The major peak at 3.8 min (detection at 204 nm) is identical with 114 
alliin based on its identical UV spectrum and detection time with those of a reference 115 
standard.116 
 117 
Figure 1. High-performance liquid chromatography (HPLC) spectrum analysis: HPLC 118 
chromatogram of the WGLL reporting one major peak at 3.8 min. 119 
 120 
2.2. Echocardiographic Analyses.  121 
All echocardiographic examinations were completed within a 20-minute time interval 122 
with outcomes shown in Table 1. End-systolic diameter (ESD) of the left ventricle measured 123 
in M-mode, exhibited significant increases in HC animals (1.242±0.045 cm for HC, versus 124 
1.016±0.091 cm noted in the Control group). Nevertheless, no change in this outcome was 125 
observed in HCT animals (1.184±0.020 cm) in comparison with this parameter in the Control 126 
group. 127 
Fractional shortening (FS) and ejection fraction (EF) data correlated strongly with 128 
measurements of both the parasternal long and short axis views. FS and EF of HC animals 129 
were significantly decreased in comparison with this outcome evaluated in animals in the 130 
control group (FSHC: 29.010±1.056 versus FSControl: 32.310±0.718 and EFHC: 49.810±1.140 131 
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versus EFControl: 56.910±1.294, respectively). Additionally, significant increases in fractional 132 
shortening were observed in in the WGLL-treated (HCT) group in comparison with the HC 133 
group (FSHCT: 32.970±1.131, and EFHCT: 55.990±1.756). Diastolic function of the left 134 
ventricle was evaluated by E/A ratios measured in Doppler (PW) mode. E/A ratios were 135 
significantly lower in the HC group in comparison to the Control animals (HC: 136 
1.207±0.037versus the Control: 1.376±0.045). These results notwithstanding, no significant 137 
changes were observed in the E/A ratios of treated animals (HCT: 1.344±0.076) in 138 
comparison to Controls. Deceleration time of the E wave (DecT) exhibited significant 139 
lengthening in the HC animals (HC: 87.440±3.534 ms versus the Control: 71.250±4.101 ms). 140 
However, DecT values of WGLL-treated animals were significantly lower compared to the 141 
HC rabbits (HCT: 69.540±4.787 ms). Tissue velocity imaging (TDI) revealed a 142 
non-significant trend toward decreased lateral E’/A’ ratios in WGLL-treated animals. 143 
Surprisingly, right ventricle function characterized by measuring peak systolic velocity (S’) 144 
waves and tricuspidal annular plane systolic excursion (TAPSE) exhibited significant 145 
improvement in WGLL-treated animals. Amplitudes of S’ waves were significantly 146 
increased in WGLL-treated animals, compared to the HC group (HCT: 9.156±0.210 cm/s 147 
versus HC: 8.103±0.216 cm/s), and TAPSE values were also significantly elevated in the 148 
WGLL-treated HCT animals compared to the HC rabbits (HCT: 0.646±0.020 cm versus. 149 
HC: 0.5762±0.015 cm). Additionally, right ventricle E’/A’ ratios of WGLL-treated animals 150 
were slightly decreased.  151 
 152 
Table 1. Echocardiographic outcomes 
mean±SEM HR (bpm) Ao (cm) LV ESD (cm) LV EDD (cm) FS PLAX (%) 
Control 180,8±4,145 0,946±0,024 1,016±0,091 1,655±0,050 39,370±5,021 
HC 150,2±4,303* 0,919±0,025 1,242±0,045* 1,756±0,063 29,220±0,803* 
HCT 185,0±7,053** 0,898±0,012 1,184±0,020 1,793±0,031 33,820±1,312** 
  EF PLAX (%) 
LV mass PLAX 
(g) FS SAX (%) EF SAX (%) 
LV mass SAX 
(g) 
Control 56,910±1,294 6,632±0,478 32,310±0,717 54,130±0,961 6,573±0,351 
HC 49,810±1,140* 8,218±0,628 29,010±1,056* 49,430±1,517* 8,315±0,792* 
HCT 55,990±1,756** 8,769±0,169* 32,970±1,131** 54,930±1,522** 8,195±0,226* 
  E/A DecT (ms) E/E'  
LVOTVmax 
(cm/s) LVOTVTI (cm) 
Control 1,376±0,045 71,250±4,101 1,417±0,058 84,280±2,131 0,071±0,002 
HC 1,207±0,037* 87,440±3,534* 1,775±0,101 87,940±5,719 0,080±0,005 
HCT 1,344±0,076 69,540±4,787** 1,718±0,155 77,150±2,157 0,0685±0,002 
  E'/A' (lateral) MAPSE (cm) RV S' (cm/s) RV E'/A' TAPSE (cm) 
Control 1,303±0,058 0,527±0,018 8,935±0,273 1,336±0,051 0,576±0,012 
HC 1,109±0,071 0,571±0,025 8,103±0,215* 1,233±0,092 0,576±0,015 
HCT 1,065±0,117 0,592±0,030* 9,156±0,210** 1,055±0,077* 0,644±0,020** 
 153 
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Table 1. Echocardiographic outcomes. Outcomes of echocardiographic evaluations on 154 
animals fed normal cholesterol-free rabbit chow (Control); normal rabbit chow, containing 155 
2 % cholesterol (HC); rabbit chow containing 2% cholesterol + 2% WGLL (HCT). 156 
Outcomes evaluated included the following: heart rate (HR); beats per minute (bpm); aortic 157 
diameter (Ao); left ventricle (LV); right ventricle (RV); end-systolic diameter (ESD); 158 
end-diastolic diameter (EDD); parasternal long axis view (PLAX); short axis view (SAX); 159 
fractional shortening (FS) of the left ventricle; ejection fraction of the left ventricle (EF); 160 
calculated weight of the left ventricle (LV mass); peak mitral early diastolic inflow 161 
velocity/peak atrial diastolic inflow velocity (E/A); decelaration time of the E wave from 162 
maximum to baseline (DecT); peak mitral inflow velocity/avarage of spectral tissue 163 
Doppler peak early diastolic velocities at the septal and lateral corner of mitral annulus 164 
(E/E’); maximal velocity of left ventricle outflow (LVOTVmax); left ventricle outflow tract 165 
velocity time integral (LVOTVTI); peak early diastolic velocity of the lateral wall, spectral 166 
tissue Doppler/peak atrial diastolic velocity of the lateral wall, spectral tissue Doppler 167 
(E’/A’); peak systolic velocity (S); mitral annular plane systolic excursion (MAPSE); and 168 
tricuspidal annular plane systolic excursion (TAPSE). 169 
* P<0.05 in comparison to mean values of Control group. 170 
** P<0.05 in comparison to mean values of HC group. 171 
2.3. Cardiac Function in Isolated Working Hearts 172 
Figure 2 shows the effect on cardiac functional parameters of elevated dietary 173 
cholesterol-induced hypercholesterolaemia and WGLL treatment. Cardiac functions 174 
evaluated included: aortic flow (AF, 2A), coronary flow (CF, 2B), aortic pressure (Aop, 2C), 175 
heart rate (HR, 2D), cardiac output (CO, 2E) and stroke volume (SV, 2F). Measurement of 176 
these functions in animals in the HC and HCT groups revealed decreases in AF, HR, and CO 177 
for basal functions of the perfused hearts, compared to Controls (P<0.05). There were 178 
significant increase under preischemia AoP, both in hypercholesterolemic and WGLL 179 
treated hypercholesterolemic groups, compared to the Control group (P<0.05). After 60 180 
minutes of reperfusion, animals in all groups showed decreases in AF, CF, HR, and CO 181 
compared with preischemic values. Significant increases in recovery of AF and HR were 182 
observed in the WGLL-treated group, compared with the other groups (P<0.05). Subsequent 183 
correlation with results of echocardiographic measurements (Table 1) further supported the 184 
cardioprotective capacity of WGLL. 185 
 186 
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 187 
Figure 2. Effect of high cholesterol and WGLL on cardiac function. Hearts 188 
were isolated from 3 groups of animals (n=6), defined as follows: 189 
non-hypercholesterolemic animals fed with normal chow (Control); 190 
hypercholesterolemic group fed with 2 % cholesterol-supplemented chow (HC); 191 
and a group of hypercholesterolemic animals treated with WGLL (HCT). Isolated 192 
working hearts harvested from each animal in each group were subjected to global 193 
ischemia followed by 120 minutes of reperfusion (I/R). Cardiac functions were 194 
registered before ischemia (Preischemic) and 60 es after global ischemia (60 195 
minutes of Reperfusion). Results are shown as average values from each group of 196 
rabbits ±SEM of aortic flow (AF, ml/min, 2A); coronary flow (CF, ml/min, 2B); 197 
Aortic pressure (AoP, Hgmm, 2C); Heart rate (HR, beat/min, 2D); Cardiac output 198 
(CO, ml/min, 2E); Stroke volume (SV, ml, 2F). *P <0.05 compared with 199 
Preischemic Control. **P<0.05 compared with 60 minutes of Reperfusion Control. 200 
##P<0.05 compared with 60 minutes of Reperfusion HC. 201 
 202 
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2.4. Western Blot Analysis for Biomarkers of Cardiac Tissue Function 203 
Myocardial tissue levels of four major mediators of cardiac homeostasis, measured by 204 
Western blot analysis, is shown in Figure 3. The outcomes of treatments administered to 205 
rabbits in these experiments revealed that expression of HO-1 protein was significantly 206 
greater in tissue harvested from HCT animals, compared to the levels observed in the HC 207 
group (3A, P<0.05). Tissue expression of SOD-1 in the HC group was observed to be 208 
significantly higher compared to Control and HCT animals (3C, P <0.05). COXIII and 209 
VEGF proteins were expressed at lower levels both in HC and HCT groups versus quantities 210 
of these proteins found in hearts harvested from the Control animals (3B, 3D, P <0.05). 211 
 212 
 213 
Figure 3. Cardiac tissue biomarker expression: Western blot outcomes. 214 
Expression of HO-1 (3A), COXIII (3B), SOD-1 (3C) and VEGF (3D) protein in 215 
rabbit myocardial tissue, was measured in homogenized left ventricular cardiac 216 
tissue samples drawn from 3 test groups (n=6), defined as follows: I/R injured 217 
from non-hypercholesterolemic animals fed with normal, non-cholesterol 218 
supplemented chow (Control); I/R injured hearts from hypercholesterolemic 219 
animals fed with 2 % cholesterol-supplemented chow (HC); and I/R-injured hearts 220 
harvested from hypercholesterolemic animals fed with 2 % cholesterol and 2 % 221 
Wild garlic leaf lyophilisate-supplemented chow (HCT). GAPDH and COXIV 222 
expression level was measured as reference protein. Western blot analysis were 223 
conducted on each tissue homogenate in duplicate, and the signal intensity of 224 
resulting bands corresponding to proteins of interest was measured using the Scion 225 
for Densitometry Image program, Alpha 4.0.2.3. Tissue content of each protein is 226 
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shown in arbitrary units as the mean for each group of animal ±SEM. * P<0.05 for 227 
comparison of average expression levels of HO-1, COXIII, SOD-1 and VEGF in 228 
myocardium to non-hypercholesterolemic group (Control). # P<0.05 for 229 
comparison to hypercholesterolemic group (HC). 230 
2.5. Rabbit Aortic Histology 231 
Histological sections of aortas stained with hematoxylin-oil red O from the 3 groups are 232 
shown in Figure 4. No atherosclerotic lesions were observed in sections of these blood 233 
vessels harvested from the Control animals fed normal rabbit chow (4A). At the end of the 8 234 
week-treatment period, up to 35% of the total aortic area harvested from HC animals was Oil 235 
red O positive (4B). The extent of atherosclerotic lesions observed in animals within the HC 236 
group was significantly increased (4D, 38.610%±0.146) in comparison to lesional coverage 237 
in aortic sections taken from animals in the Control group (P<0.05). Discrete lesion 238 
formation was visualised by oil red O stain and consecutive quantitative analysis in aortas 239 
form HCT group rabbits (4C). Aortas harvested from WGLL-treated animals in HCT group, 240 
exhibited significantly reduced atherosclerotic lesional coverage in comparison with the HC 241 
group (4D, 16.710%±3.421, P<0.05). 242 
 243 
 244 
Figure 4. Aortic histologic analysis. Histological sections of aortas from 3 groups 245 
of rabbits stained with hematoxilin-oil red O (A, B, C, magnification x25). Bright 246 
red-stained lipid shows atherosclerotic plaques in the HC (4B) and HCT groups 247 
(4C). Internal elastic lamina is shown in Figures 4 IE; M, media; P, atherosclerotic 248 
plaques; and F, adventitial fatty tissue stained with oil red O. *P<0.05 for 249 
comparison with Control group outcomes. #P<0.05 for comparison with HC group 250 
outcomes. 251 
2.6. Serological Correlates of Experimental Treatments 252 
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The outcomes of analyses of peripheral blood serum from animals treated with selected 253 
dietary regimens are shown in Table 2. Fasting plasma TC and LDL cholesterol were two 254 
orders of magnitude higher, and HDL cholesterol concentration was 8-fold higher, in HC and 255 
6-fold higher in HCT groups, compared to levels of these analytes in the serum of the Control 256 
group animals (P<0.05). However, significantly lower plasma TC and LDL cholesterol 257 
levels were observed in HCT, versus the HC groups (P <0.05), showing a possible protective 258 
effect of the WGLL. Moreover, ApoA levels detected in blood of HC animals (0.022±0.003) 259 
were significantly lower, versus those of the Control rabbits fed diets with normal cholesterol 260 
content (0.042±0.005) and WGLL-treated rabbits in the HCT group (0.056±0.008, P <0.05). 261 
No significant differences were noted between serum ApoA content of serum from animals 262 
in the Control group, versus HCT groups (P> 0.05). Serum levels of ApoB in rabbits from 263 
both HCT and HC groups were significantly higher as compared to the Control group (P 264 
<0.05). Moreover, ApoB levels detected in the serum of rabbits in the HCT group 265 
(0.172±0.019) were significantly lower compared with the content of this analyte in the HC 266 
group (0.280±0.063, P <0.05). Additionally, no significant differences were observed 267 
between the serum TG content of these three groups. It was further noted that the serum 268 
content of the pro-inflammatory biomarker c-reactive protein (CRP), was increased 269 
significantly in blood from HC animals, compared to the Control group. GOT liver enzyme 270 
levels were elevated in blood of HC group animals (48.8±16.22), as compared to the Control 271 
and HCT groups (29.670±2.895, 24.910±2.708; P <0.05). LDH (316.6±37.17) and CK 272 
(2851±600.800) serum levels were significantly decreased in the HCT group compared to the 273 
HC group (791.90±325.4, 496±135; P <0.05). 274 
 275 
Table 2. Serum biomarkers of cardiac function. 
 
Groups 
 
TC 
 
LDL-C 
 
HDL-C 
 
ApoA 
 
ApoB 
 
Control 
 
0,793±0,067 
 
0,230±0,023 
 
0,523±0,045 
 
0,042±0,005 
 
0,015±0,003 
 
HC 
 
26,370±3,660*,# 23,550±3,032*,# 4,427±0,656* 0,022±0,003*,# 0,280±0,063*,# 
 
HCT 
 
20,030±1,947*,** 17±1,942*,** 3,314±0,369* 0,056±0,008** 0,172±0,019*,** 
 
  
TG 
 
CRP 
 
GOT 
 
 
LDH 
 
CK 
 
Control 
 
 
0,788±0,035 
 
0,100±0,014 
 
29,670±2,895 
 
726,400±170,700 
 
4213±623,200 
 
HC 
 
1,367±0,335 0,728±0,362* 48,800±16,220* 791,900±325,400 4955±1353 
 
HCT 
 
1,052±0,339 
 
0,596±0,231 
 
24,910±2,708** 316,600±37,170** 2851±600,800** 
 
Table 2. Serum biomarkers of cardiac function. 276 
Average serum TC, TG, LDL-C, HDL-C (mmol/L), ApoA and ApoB (g/L), sCRP (mg/L), 277 
sGOT, sLDH and sCK (U/L) levels in 3 groups of rabbits (n=6), were analysed by 278 
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hematology analyser. Each analysis was conducted on peripheral blood serum harvested 279 
from animals following the 8-week treatment periods, for: non-hypercholesterolemic 280 
(Control), hypercholesterolemic rabbits (HC) and hypercholesterolemic animals receiving 281 
WGLL-supplemented chow (HCT). Results are shown as average values from each group 282 
animals ±SEM of serum total cholesterol (serum cholesterol, mmol/L) and low-density 283 
lipoprotein cholesterol (LDL-C, mmol/L). 284 
*p<0.05 compared with Control group values. 285 
**p<0.05 compared with HC group values. #p<0.05 compared with HCT group values. 286 
3. Discussion 287 
As described in the Results section 3.1 of this report, bioanalytical analysis of a 288 
representative WGLL sample revealed the leaf to contain 0.261% alliin by weight, a 289 
property of this material that contributes to its ability to mitigate expression of other 290 
biomolecules described here, which are involved in the atherosclerotic pathophysiologic 291 
processes. This natural component of fresh garlic is a sulfoxide derived and forms from the 292 
amino acid cysteine [25], and is a major contributor to the capacity of garlic extracts to 293 
scavenge hydroxyl radicals, along with a wide variety of other antioxidant properties that 294 
counteract oxidative tissue damage [26]. Alliin has also been demonstrated to potently 295 
stabilize and strengthen immunoregulation, contributing to well-known curative properties 296 
of garlic [27]. 297 The outcomes of echocardiographic analyses conducted on live animals shown in 
Table 1. reveal the effect of elevated dietary cholesterol and WGLL treatment. The 298 
physiologic significance of these results may be stated according to 4 major interpretations 299 
of the data shown. These may be summarized as follows: 300 
(1) The observed stability throughout the evaluation period of heart rates, respiratory 301 
frequencies, M-mode and Doppler measurements demonstrate that basal cardiopulmonary 302 
activity was not substantially disrupted by hypercholesteremia, an outcome for which 303 
preliminary evidence was provided by an earlier study conducted in the laboratory of the 304 
authors [28]. 305 
(2) Moreover, in comparison to untreated control rabbits fed a normal diet, left 306 
ventricular end-systolic diameter (ESD) measured in HC animals was significantly 307 
increased, with or without WGLL treatment, along with decreased fractional shortening and 308 
ejection fraction in HC (ii) animals – and a strong correlation was found between fractional 309 
shortening (FS) and ejection fraction (EF) data measured on both the parasternal long and 310 
short axis views. Also, the effects of WGLL treatment included observations that, relative to 311 
HC animals not receiving the lyophilisate, HCT rabbits showed significant increases in 312 
fractional shortening. Pathologically increased ESD is associated with greater risk of 313 
mortality in heart disease [29], and decreased FS and ES have recently been implicated as 314 
contributors a to fibrotic disease [30]. These results suggest that WGLL will contribute to 315 
survival of cardiac patients and lower propensity for development of fibrosis. 316 
(3) Table 1 diastolic function data, generated in Doppler (PW) mode also reveals that 317 
elevated dietary cholesterol resulted in significantly lower left ventricular E/A ratios 318 
relative to those observed in control animals. WGLL-treated animals showed values close 319 
to controls. Moreover, significant lengthening was observed in deceleration time of the E 320 
wave (DecT) in HC animals, showing an abnormal diastolic filling pattern of the ventricle, 321 
which was counteracted by WGLL-supplemented diet, indicates slightly improved diastolic 322 
function. 323 (4) Finally, surprisingly significant increases were shown in Table 1, in right 
function mediated by WGLL treatment of animals fed elevated cholesterol diets, which 324 
obtained through evaluation of peak systolic velocity (S’) waves and tricuspidal annular 325 
plane systolic excursion (TAPSE). Reduction of peak systolic velocity identifies the 326 
of RV dysfunction with high sensitivity. This reduction was significant in HC animals but 327 
Int. J. Mol. Sci. 2016, 17, x 11 of 5 
 
was counteracted fully by WGLL treatment, showing that the aforementioned beneficial 328 
effects of WGLL supplementation can be seen on right ventricle function as well. In heart 329 
failure patients, the reduction of tricuspidal annular systolic velocity is associated with the 330 
severity of RV dysfunction. Surprisingly, TAPSE values in WGLL-treated group were 331 
significantly increased even compared to healthy animals. These findings indicates that diet 332 
supplemented with WGLL could have positive effects on right ventricle systolic function, 333 
but the relevance of this effects and the underlying mechanisms need further investigations. 334 
Evaluation of cardiac functions in Langendorff-mounted isolated working hearts shown 335 
in Figure 2 revealed significantly increased preischemic AoP values in both the 336 
hypercholesterolemic and WGLL-treated hypercholesterolemic groups, relative to untreated 337 
Control rabbits. Also, as shown in Figure 2, ischemic-reperfusion injury-associated 338 
decreases in AF, CF, HR, and CO, versus preischemic values, along with significantly 339 
increased recovery of AF and HR in animals fed the lyophilisate, further supported 340 
anti-ischemic properties of WGLL. These effects are consistent with previous studies by the 341 
authors, in which interventions that decrease oxidative stress on cardiac tissue, dramatically 342 
improved recovery from ischemic events [31-33]. An interpretation of the significance of 343 
these outcomes to the cardioprotective ability of WGLL should be considered in the context 344 
of the fact that myocardial ischemic events typically reduce cardiac aortic blood pressure 345 
(AoP), along with reduction in myocardial metabolic requirements, coronary blood flow, and 346 
left ventricular tension. For these reasons, influences that decrease AoP may be either 347 
detrimental or beneficial [34]. Thus, whereas increased preischemic AoP in HC animals 348 
indicates that such an increase is pathological for animals maintained on a high cholesterol 349 
diet, the failure of WGLL treatment to lower AoP suggests that the extract has negligible 350 
effect on this aspect of cardiovascular function. 351 
Data described in section 3.4 of the Results section of this article and shown in Figure 3, 352 
provide ventricular tissue expression profiles of proteins implicated in pathogenesis and 353 
adaptive response to atherosclerotic disease. Western blot analysis of myocardial tissue, 354 
reveals significantly elevated content of HO-1 protein in tissue harvested from HCT 355 
animals, versus that taken from rabbits in the HC group. The heat shock protein HO-1 356 
(hsp-32) is a major antioxidant defense enzyme, which is increased in response to trauma 357 
intrinsic to a wide range of diseases, including (and especially) atherosclerotic syndromes 358 
[35]. Often, the effects of a disease process overwhelm the protective capacity afforded by 359 
endogenous HO-1 expression[36-38]. However, its cardioprotective effects may be greatly 360 
amplified by administration of pharmacological inducers, as demonstrated by the authors of 361 
the present report [28]. The cytoprotective effects correlating with increased expression of 362 
HO-1, are a likely effect of heme degradation by this enzyme to produce bilirubin and 363 
carbon monoxide (CO), both of which enhance healthy function of cardiovascular tissue at 364 
the concentration normally produced by HO-1 activity during normal heme clearance. 365 
Therapeutic amplification of HO-1 in these studies was achieved using seed kernel 366 
extracts of Prunus cerasus (sour cherry). The present investigation demonstrates that 367 
lyophilisate of wild garlic leaf also mediates this effect. However, since this plant material 368 
also stimulates other protective effects, based on the data shown here, it cannot be 369 
determined to what extent WGLL-induced HO-1 expression contributes to the specific 370 
cardioprotective outcomes revealed. 371 
SOD1 levels measured by Western blot analysis in myocardial tissue of HC animals after 372 
ischaemia/reperfusion injury were significantly elevated compared to the Controls, while 373 
SOD1 expression in WGLL treated animals was maintained at the normal (Control) levels. 374 
Both apoptotic signaling and adaptive responses to oxidative stress, involve processes for 375 
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which SOD1 activity is a critical component. This enzyme produces molecular oxygen and 376 
hydrogen peroxide (H2O2) as an end metabolites of its main activity, which is to neutralize 377 
superoxide [39]. H2O2 is itself a toxic reactive oxygen species (ROS) and may contribute to 378 
ischemia-reperfusion injury of myocardial tissue, through abnormally high apoptotic 379 
signaling and oxidative tissue damage in ischemic heart disease [40].  380 
SOD1 is known to have a capacity to limit the detrimental effects of ROS by eliminate O2- 381 
to produce H2O2 which is eliminated by Glutathione peroxidase or by Catalase to harmless 382 
H2O and O2, but on the other hand, with free iron(II) H2O2 also can form free hydroxyl 383 
radicals by Fenton’s reaction (see graphical abstract). High SOD levels along with 384 
considerable amounts of Fe2+ are associated with increased production of the highly toxic 385 
hydroxyl radical, and may even enhance the extent of reperfusion injury [41]. An unbalance 386 
between the production of prooxidant H2O2 (SOD1) and antioxidants, such as Glutathion 387 
peroxidase and Catalase in the cell might lead to a strengthened production of free radicals 388 
which could lead to serious cellular damage. This is supported by assessment of SOD 389 
activity in blood of MI patients, which revealed that relative to healthy control individuals, 390 
SOD levels in the patient group were significantly higher [42]. This difference likely reflects 391 
a normal adaptive response to limit oxidative damage to the myocardium imposed by 392 
ischemic (and other) tissue injury. 393 
Western blot analyses conducted in this investigation, revealed that COXIII and VEGF, 394 
which are both implicated in the pathophysiology of cardiovascular syndromes were 395 
expressed at lower levels both in HC and HCT groups, versus quantities of these proteins 396 
found in hearts harvested from the Control animals. In COXIII and VEGF protein levels, 397 
there were no significant changes between WGLL-treated and hypercholesterolemic 398 
groups. Our results suggest that wild garlic may develop its cardioprotective activity via 399 
heme/HO system, and has no effect on COXIII and VEGF proteins. 400 
The extent of atherosclerotic plaque coverage on the intimal surface of 401 
hematoxylin-Oil red O-stained rabbit aortas reveals negligible plaque on sections harvested 402 
from Control animals maintained on diets with normal cholesterol content, and lesional 403 
extent of approximately 35% in sections from HC rabbits (Figure 4). The significantly 404 
reduced lesional coverage observed in WGLL-treated rabbits fed high cholesterol chow 405 
(HCT) is an effect also observed in previous work by these authors, in which HO-1 406 
expression increased by adding sour cherry seed kernel extract to rabbit chow. This 407 
protected against dietary cholesterol-induced arterial plaque formation [28]. 408 
The blood of animals utilized in the present study was evaluated for serum analytes 409 
expressed at levels which may be used as diagnostic and therapy effect indicators for 410 
cardiovascular disease severity along a wide range of other severe inflammatory 411 
The outcomes of serum parameter measurements are shown in Table 2. They reveal 412 
significantly elevated fasting plasma levels of TC and LDL cholesterol, which were two 413 
orders of magnitude higher, and HDL cholesterol concentration, which was 8-fold higher, 414 
HC and 6-fold higher HCT rabbits versus the Controls, effects that are an expected result of 415 
high cholesterol diets [43]. However, elevated levels of HDL cholesterol in WGLL-treated 416 
rabbits may indicate a cardioprotective property of the lyophilisate in the context of 417 
beneficial effects of HDL. Significantly lower TC and LDL cholesterol levels were 418 
in WGLL-treated (HCT) animals versus groups fed with high cholesterol chow but no 419 
WGLL (HC), demonstrating that the lyophilisate is protective with respect to influence of 420 
these analytes. ApoA levels in blood of HC animals were significantly lower versus rabbits 421 
fed normal chow (Control). Thus, the lack of significant differences in ApoA content of 422 
blood from animals fed normal diets (Control) versus content of this molecule in 423 
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WGLL-treated rabbits maintained on high cholesterol (HCT) indicated a normalizing effect 424 
of the lyophilisate on this outcome. The significance of this result is that ApoA-I deficiency 425 
causes both hypertriglyceridemia and increased atherosclerosis in animal models [44], 426 
can be counteracted by WGLL-supported diet. 427 
Analysis of ApoB revealed that systemic levels of this analyte in rabbits from both 428 
HCT and HC groups were significantly higher versus its levels in blood of animals fed 429 
chow with normal cholesterol content (Controls). Moreover, ApoB levels detected in blood 430 
taken from rabbits in the HCT group were significantly lower in comparison to content of 431 
this analyte in the HC group. This result is well correlated with LDL levels measured in the 432 
two groups. This finding was expected since ApoB is the primary apolipoprotein of 433 
chylomicrons, VLDL, IDL, and LDL particles. 434 
Elevation in serum TG of the HC group was tendentious but not significant compared to 435 
that of the Controls. One interpretation is that triglyceride metabolism is unaffected by 436 
either influence within the constraints of the present study. Further analysis of blood from 437 
each of the three test groups revealed significant elevation of c-reactive protein (CRP) in 438 
HC animals versus the Controls. Since CRP is a reliable systemic indicator of a wide range 439 
of inflammatory pathologies, this result implies that levels of dietary cholesterol 440 
administered to animals in this study managed to induce onset of inflammatory processes. 441 
Analysis for serum liver enzyme activities demonstrated significantly elevated GOT in 442 
blood of HC group animals versus the Control and HCT groups, suggesting a hepatotoxic 443 
effect of elevated dietary cholesterol intake, an effect noted by previous investigators [45]. 444 
Finally, the significantly lower levels of LDH and CK observed in HCT animals, versus 445 
group rabbits maintained on high cholesterol (HC), indicated that effects of dietary 446 
supplementation with WGLL may have beneficial effects on impaired liver function caused 447 
by hypercholesteroleamic state. TNFα-induced ICAM-1 mRNA transcription, which has 448 
been demonstrated by in vitro studies to suppress adhesion of monocytes to porcine arterial 449 
tissues and HUVECs, was significantly inhibited by treatment with Alliin 450 
(S-Allyl-L-Cysteine Sulfoxide).  Moreover, Alliin is also protected against depolarization of 451 
mitochondrial membrane potential and overproduction of the superoxide anion, which occur 452 
as a downstream effect of TNFα – and may correlate with suppression of NOX4 mRNA 453 
transcription by HUVECs. Additionally, treatment of HUVECs with Alliin was also 454 
observed to reduce TNF-alpha-mediated ERK1/2 IjB, and IjB (but not p38) phosphorylation.  455 
These results provide improved insight into the mechanisms by which Alliin acts as a 456 
countermeasure to atherosclerotic pathomechanisms [46] and are consistent with the 457 
protective effects of the plant extract reported here. 458 
4. Experimental Section (methodology). 459 
4.1. Sample lyophilization and Bioanalytics. 460 
Deep-frozen Allium ursinum leaves (Toltelekgyar Ltd., Zalakomar, Hungary) were 461 
lyophilized for 24 hours in a Martin-Christ ALPHA 1-4 freeze dryer (Martin Christ 462 
Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) at an ambient pressure of 463 
0.120 millibars (mb), with a condensor temperature of -50°C and shelf temperature of 35°C. 464 
The ratio of the frozen, leaf to fresh and desiccated plant material was 5:6:1. HPLC analysis 465 
was accomplished using a Waters 600 system (Waters Corporation, Milford, CT, USA), 466 
equipped with a 2998 photodiode array detector, on-line degasser, and auto sampler, using a 467 
reversed phase Phenomenex Synergi 4 µm Hydro-RP 80Å (250 mm x 4.6 mm) column 468 
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(Phenomenex, Torrance, CA, USA). With a column temperature of 25°C, a gradient elution 469 
was applied as follows: 0-15 minutes: 100% of mobile phase A (water + 0.1% phosphoric 470 
acid); 15-20 minutes: the ratio of mobile phase B (acetonitrile) increased to 100%; 20-25 471 
minutes: 100% B; 25-27 minutes: A increased to 100%; 27-45 minutes: 100% A. The flow 472 
rate was 0.75 ml/min, and alliin was monitored at 204 nm. Alliin was detected at 4.6 minutes. 473 
Data acquisition and evaluation were performed using Empower Pro software. 474 
Alliin was purchased from LGC Standards. Acetonitrile used for chromatographic 475 
analysis (LiChrosolv® HPLC grade) was obtained from Merck (Darmstadt, Germany). 476 
Millipore Direct-Q UV3 clarifier (Molsheim, France) was used to produce purified water for 477 
HPLC measurements. Stock standard solutions of alliin were prepared with methanol and 478 
stored at 4°C. The calibration range was 0.5–5 µg alliin/injection. The calibration standard 479 
was injected in triplicate at six volume levels. Extraction alliin from the lyophilized plant 480 
material was carried out with 10 ml MeOH at room temperature for 3 minutes from 1 g 481 
sample in an ultrasonic bath. After filtering through a filter membrane (Acrodisc® GHP 13 482 
mm, 0.45 µm, Waters Corporation, Milford, CT, USA), 3 independently prepared samples 483 
were analyzed in triplicate. 484 
4.2. Animals 485 
The experiments were carried out using adult male New Zealand rabbits with an average 486 
body weight of 2.5-3.0 kg. The animals received human care in compliance with “Principles 487 
of Laboratory Animal Care” by EU Directive 2010/63/EU for animal experiments. The 488 
duration of the adaptive feeding was 2 weeks. The rabbits were provided with laboratory 489 
rodent chow, or chow enriched with 2.0% cholesterol (Jurasko, Debrecen, Hungary), or 490 
cholesterol-supplemented chow containing 2% wild garlic leaf lyophilisate (WGLL) daily 491 
for 8 weeks ad libitum. Allium ursinum lyophilisate-containing chow was produced in the 492 
laboratory of Dept. of Pharmaceutical Technology, University of Debrecen. Comparison of 493 
behavior and general health status of animals provided with unsupplemented rabbit chow 494 
versus feed containing other components showed no observable differences, with no 495 
indication that administration of feed acted as a confounder to the experiments conducted. 496 
4.3. Echocardiograpy. 497 
Echocardiographic examination of animals was conducted under light anesthesia 498 
(ketamine 15 mg/kg, xylazine 3 mg/kg (i.m.) at the 8-week timepoint of the study [47]. The 499 
chest of each animal was shaved, and the rabbit was positioned in a dorsal decubitus position. 500 
Echocardiographic measurements were performed using a Siemens Acuson 512 sonograph, 501 
with 7V3c probe at 7 MHz, with fundamental imaging (Figure 4). Conventional 502 
measurements were carried out in 2D and M-mode. Parasternal long axis views were 503 
obtained and recorded to ensure that the mitral and aortic valves, as well as the apex, were 504 
visualized. The parasternal short axis views were recorded at the mid-papillary muscle level. 505 
M-mode tracings were performed at the mid-papillary muscle level, either in parasternal long 506 
or short axis views. M-mode for visualization and quantification of wall motion in 507 
cardiovascular research was used; single line acquisition allows for the very high-temporal 508 
(1000 fps) resolution necessary for analysis of LV function. Echocardiographic 509 
measurements included interventricular and left ventricular free-wall thickness in diastole 510 
and systole (IVSs, IVSd) and left ventricular internal diameter at end-diastole (LVIDd) and 511 
end-systole (LVIDs). End-systolic volume (ESV), end-diastolic volume (EDV), stroke 512 
volume (SV), and left ventricular mass were calculated. Fractional shortening was computed 513 
by using the equation [(LVIDd – LVIDs) / LVIDd] × 100%, and ejection fraction was 514 
calculated by using the following formula (Teiholz): EF = (LVEDD2-LVESD2)/LVIDD2. 515 
Mitral and tricuspid annular peak systolic excursions (MAPSE and TAPSE) were assessed 516 
with M-mode, measuring the distance of mitral or tricuspid annular movement between 517 
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end-diastole to end- systole. All measurements were averaged over three to five consecutive 518 
cardiac cycles. 519 
Doppler (PW) imaging of the mitral valve and aortic valve were obtained from the apical 520 
4-chamber view and the apical 5-chamber view. From the mitral inflow velocity image, the 521 
following measurements were obtained: peak E and peak A waves (mitral early and late 522 
filling velocities), E to A ratio (E/A), deceleration time of early filling velocities (DecT). 523 
Aortic and left ventricular outflow tract (LVOT) parameters were also calculated: 524 
LVOTVmax, LVOT maxPG, and LVOTEnvTi. 525 
Tissue velocity imaging (TVI) measurements were analyzed from the apical 4-chamber 526 
view and from the parasternal long axis and short axis views as well. A 5-mm tissue sampling 527 
volume was obtained at the mitral annulus from both septal and lateral walls. From the 528 
acquired images, the following functional parameters were measured: S’, E’/A’ wave 529 
velocities, E/E’ (early diastolic mitral inflow velocity divided by average value of lateral 530 
and septal tissue Doppler early diastolic velocities), and E’/A’ (tissue Doppler early and 531 
late diastolic velocity ratio) [48]. 532 
 533 
 534 
Figure 5. Representative images of echocardiographical measurements. A: 535 
Doppler image, mitral inflow velocities; B: color Doppler image, velocity of left 536 
ventricle outflow tract; C: M-mode image, tricuspidal annular plane systolic 537 
excursion (TAPSE); D: M-mode image, parasternal long axis view (PLAX) of left 538 
ventricle. 539 
4.4. Measurement of Serum Parameters. 540 
Blood samples were collected with EDTA-K2 evacuated tubes (BD Vacutainer, USA) 541 
from the marginal ear vein of the animals, at the endpoint of the treatment. The samples were 542 
collected and processed aseptically to minimize hemolytic activity. Serum level of total 543 
cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low 544 
density lipoprotein cholesterol (LDL-C), and value of Apolipoprotein A-I (ApoA), 545 
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Apolipoprotein B (ApoB), C reactive protein (CRP), Aspartate transaminase (also called 546 
Glutamic oxaloacetic transaminase, GOT), Lactate dehydrogenase (LDH), and Creatine 547 
kinase (CK) were detected by automated analyzers in the Department of Laboratory 548 
Medicine at the University of Debrecen. 549 
4.5. Isolated Working Heart Preparation (Langendorff Method). 550 
Each of the animals were anaesthetized with a mixture of ketamine/xylazine (50/5 551 
mg/kg, intramuscularly). A bolus of heparin was administered (1,000 U/kg of body weight, 552 
intravenously) 20 minutes before thoracotomy, to avoid thrombosis. Next, the chest cavity 553 
was opened and the pericardium incised. The heart was excised and immediately transferred 554 
to ice-cold modified Krebs-Henseleit (mKH) buffer (pH 7.4 on 37°C, gassed with 95% O2 555 
and 5% CO2 mixture) [49]. The aorta was then cannulated and the heart perfused for 10 556 
minutes, retrogradely in Langendorff mode with mKH buffer to clear residual blood from 557 
each harvested organ. The perfusate had the following composition: NaCl, 118 mmol/l; 558 
NaHCO3, 25 mmol/l; KCl, 4.8 mmol/l; CaCl2, 1.8 mmol/l; Mg2SO4, 1.2 mmol/l; KH2PO4, 559 
1.2 mmol/l; and 10 mM glucose. A dual-headed peristaltic pump controlled the rate of 560 
perfusion of mKH buffer. The left atrial appendage was incised, and the pulmonary veins 561 
were ligated. A small incision was made at the bifurcation of pulmonary arteries; thus all 562 
coronary effluent was collected by the pulmonary artery. Next, the circulation was switched 563 
to anterograde perfusion, in order to set the baseline parameters in working heart mode for 20 564 
minutes. 565 
The following parameters were recorded and resulting data analyzed using a pressure 566 
transducer attached to the aortic outflow line: aortic pressure (AoP), heart rate (beats/min), 567 
left ventricular developed pressure (LVDP). Aortic flow (AF, ml/min) and coronary flow 568 
(CF, ml/min) were measured by using flowmeter. Hearts were then subjected to 30 minutes 569 
of global ischemia, then perfused for 15 minutes in Langendorff mode and converted to 570 
working heart mode for 105 minutes. The above-listed outcomes were measured and 571 
recorded during the reperfusion at the 30-, 60-, 90-, and 120-minute timepoints. Immediately 572 
following 120 minutes of reperfusion, small myocardial biopsies from LV heart tissue were 573 
removed and frozen for subsequent molecular biological analysis. 574 
4.6. Histological Analysis of the Aortic Root. 575 
Lipid staining was carried out with Oil red O (Sigma Diagnostics, St. Louis, MO, USA) 576 
by use of the following protocol: aortic tissues were frozen in OCT medium (Thermo Fisher 577 
Scientific Inc., Waltham, MA, USA). Cryostate tissue sections were cut to a thickness of 6.0 578 
µm and applied to Superfrost Plus slides (Daiggers, Vernon Hills, IL, USA). Atherosclerotic 579 
lesions in the aortic root were examined at 3 locations and each separated by 120µm. 4 to 5 580 
serial sections were prepared from each location, starting beyond the aortic arch. The 581 
sections were stained, as described previously, with Oil red O, followed by analysis of the 582 
lipid composition of the lesions, by calculating the percentage of Oil red O positive area, 583 
relative to the total cross-sectional vessel wall area. Nuclei were counterstained with 584 
hematoxylin (Sigma Diagnostics), using routine methods. All images were captured with a 585 
binocular light microscope (Carl Zeiss Microscopy GmbH, Jena, Germany) equipped with a 586 
video camera and analyzed using Scion Image software (Scion Corp., Torrance, CA, USA). 587 
4.7. Extraction of Myocardial Protein. 588 
300 mg frozen tissues from rabbit left ventricular myocardium were homogenized in 800 589 
µl Buffer A (25 mM Tris-HCl, pH 8, 25 mM NaCl, 4 mM Na-orthovanadate, 10 mM NaF, 10 590 
mM Na-Pyrophosphate, 10 nM Okadaic acid, 0.5 mM EDTA, 1 mM PMSF, and 1x Protease 591 
inhibitor cocktail (Sigma-Aldrich, St. Louis, Missouri, U.S.A.) in a Polytron-homogenizer. 592 
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Homogenates were centrifuged at 2,000 rpm at 4°C for 10 minutes. Supernatant from the 593 
above centrifugation was further centrifuged at 10,000 rpm at 4°C for 20 minutes, and the 594 
resulting supernatant was used as cytosolic extract. The nuclear pellet was resuspended in 595 
400 µl of Buffer A with 0.1% Triton-X-100 and 500 mM NaCl, then lysed by incubation for 596 
one hour on ice. Homogenates were then centrifuged at 14,000 rpm at 4°C for 10 minutes, 597 
and the supernatant was used as a mitochondrial lysate. Cytosolic mitochondrial extracts 598 
were aliquoted, snap frozen, and stored at -80°C for further investigations. The total protein 599 
concentration was assayed using bicinchoninic acid (BCA) method with bovine serum 600 
albumin as the standard (Pierce, Rockford, IL, USA). 601 
4.8. Western Blot Assays for Protein Expression in Cardiac Tissue. 602 
Western blot analysis was used to evaluate left ventricular myocardial tissue for 603 
expression level of the following proteins: heme-oxygenase 1 (HO-1), superoxide-dismutase 604 
1 (SOD1), vascular endothelial growth factor A (VEGF), cytochrome c oxidase III (COXIII), 605 
cytochrome c oxidase IV (COXIV), and glyceraldehyde 3-phosphate dehydrogenase 606 
(GAPDH). The total protein concentration in cytosolic and mitochondrial extract was 607 
determined using the BCA Protein Assay Kit. Next, the protein was diluted with Laemli 608 
buffer and heated to 100°C for 10 minutes. The denaturated samples were separated by 609 
SDS/polyacrylamide gel electrophoresis (SDS-PAGE) at 120 V for 90 minutes and 610 
transferred onto nitrocellulose membrane (Bio-Rad Laboratories, Hercules, California, 611 
U.S.A.) at 100 V for 1 hour. Precision plus Protein Kaleidoscope standards (Bio-Rad 612 
Laboratories, California, U.S.A.) were used as molecular-weight standards. The membranes 613 
were blocked in 5% low fat milk blocking buffer for 90 minutes and then incubated overnight 614 
at 4°C with primary antibodies (Sigma-Aldrich, St. Louis, Missouri, U.S.A.). After being 615 
washed with tris-buffered saline containing Tween 20 (TBS-T) three times for 10 minutes, 616 
the membranes were incubated with horseradish peroxidase-labeled secondary antibody 617 
diluted 1:2,000 in TBS-T and 1% (wt/vol) nonfat dry milk for 90 minutes at room 618 
temperature. Enhanced chemiluminescent substrate (ECL, Litmus Scientific) was used to 619 
identify bands.  Detection was made by autoradiography for variable lengths of time with 620 
Medical X-Ray Film (Agfa-Gevaert N.V., Belgium). Quantitative analysis of scanned blots 621 
were carried out using Scion for Windows Densitometry Image program version Alpha 622 
4.0.3.2 (Scion Corporation, Maryland, USA). Signal intensity for bands corresponding to 623 
each protein of interest was estimated and reported in arbitrary units ± SEM. 624 
4.9. Statistical Analysis. 625 
All data are presented as average magnitudes of each outcome in a group ± standard 626 
error of the mean (SEM). Statistical analysis was performed using one-way analysis of 627 
variance (ANOVA) followed by Kruskal-Wallis multiple comparison tests with GraphPad 628 
Prism software for Windows (GraphPad Software Inc., CA, USA). Probability values (P) 629 
less than 0.05 were considered statistically significant. 630 
5. Conclusions 631 
Outcomes of the present report demonstrate that wild garlic leaf lyophilisate improves 632 
cardiac functions in isolated hearts harvested from WGLL-treated rabbits. The 633 
improvements observed include significantly better post-ischaemic values of aortic flow in 634 
treated animals compared to the HC group (p<0,05). Coronary flow measurements showed 635 
similar trends. Echocardiographic measurements showed improved diastolic heart functions 636 
in animals that ate an Allium ursinum lyophilisate-containing high-cholesterol diet. 637 
relaxation expressed as DecT and E/A ratios was found in HC animals, while parameters 638 
measured in WGLL treated animals reached normal values. Systolic function expressed as 639 
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FS and EF was also found significantly decreased in HC animals, and the process was 640 
counteracted by WGLL treatment. Interestingly, better right ventricle functions were 641 
measured in treated animals (higher peak E-wave velocity, and higher TAPSE values). 642 
Tissue staining showed significantly decreased artherosclerotic plaque formation in animals 643 
treated with HCT compared to the HC group. Total blood cholesterol levels in animals fed 644 
with 2% cholesterol-containing diet showed a dramatic increase after the 8-week period, 645 
while the values of the control group remain in the physiologic range. Cholesterol levels in 646 
animals treated with Allium ursinum lyophilisate were significantly lower compared to the 647 
HC group (p<0,05). WGLL also had notable beneficial effects on the other monitored 648 
parameters (GOT, LDH, CK). Important novelties of this present report include the 649 
that increased dietary cholesterol intake may raise the level of SOD1 in cardiac tissue, 650 
is associated with increased ROS-dependent tissue damage and this may be counteracted by 651 
WGLL treatment, furthermore, our work revealed that WGLL supplementation could 652 
the activity of HO-1-mediated cardioprotective pathway in hypercholesterolemic 653 
circumstances. 654 
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